BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Ephrin B2 (EFNB2)

July 28, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest inhibiting EFNB2 could help treat glioblastoma multiforme (GBM). In patients, high tumor levels of EFNB2 correlated with poor survival. In a huma...